» Articles » PMID: 38613810

Activating Transcription Factor 6 Alleviates Secondary Brain Injury by Increasing Cystathionine γ-lyase Expression in a Rat Model of Intracerebral Hemorrhage

Overview
Specialty Geriatrics
Date 2024 Apr 13
PMID 38613810
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Intracerebral hemorrhage (ICH) comprises primary and secondary injuries, the latter of which induces increased inflammation and apoptosis and is more severe. Activating transcription factor 6 (ATF6) is a type-II transmembrane protein in the endoplasmic reticulum (ER). ATF6 target genes could improve ER homeostasis, which contributes to cryoprotection. Hence, we predict that ATF6 will have a protective effect on brain tissue after ICH.

Method: The ICH rat model was generated through autologous blood injection into the right basal ganglia, the expression of ATF6 after ICH was determined by WB and IF. The expression of ATF6 was effectively controlled by means of intervention, and a series of measures was used to detect cell death, neuroinflammation, brain edema, blood-brain barrier and other indicators after ICH. Finally, the effects on long-term neural function of rats were measured by behavioral means.

Result: ATF6 was significantly increased in the ICH-induced brain tissues. Further, ATF6 was found to modulate the expression of cystathionine γ-lyase (CTH) after ICH. Upregulation of ATF6 attenuated neuronal apoptosis and inflammation in ICH rats, along with mitigation of ICH-induced brain edema, blood-brain barrier deterioration, and cognitive behavior defects. Conversely, ATF6 genetic knockdown induced effects counter to those aforementioned.

Conclusions: This study thereby emphasizes the crucial role of ATF6 in secondary brain injury in response to ICH, indicating that ATF6 upregulation may potentially ameliorate ICH-induced secondary brain injury. Consequently, ATF6 could serve as a promising therapeutic target to alleviate clinical ICH-induced secondary brain injuries.

References
1.
Shi M, Gong Y, Wu M, Gu H, Yu J, Gao F . Downregulation of TREM2/NF-кB signaling may damage the blood-brain barrier and aggravate neuronal apoptosis in experimental rats with surgically injured brain. Brain Res Bull. 2022; 183:116-126. DOI: 10.1016/j.brainresbull.2022.02.022. View

2.
Naranjo J, Zhang H, Villar D, Gonzalez P, Dopazo X, Moron-Oset J . Activating transcription factor 6 derepression mediates neuroprotection in Huntington disease. J Clin Invest. 2016; 126(2):627-38. PMC: 4731176. DOI: 10.1172/JCI82670. View

3.
Wang G, Li X, Li N, Wang X, He S, Li W . Icariin alleviates uveitis by targeting peroxiredoxin 3 to modulate retinal microglia M1/M2 phenotypic polarization. Redox Biol. 2022; 52:102297. PMC: 8956882. DOI: 10.1016/j.redox.2022.102297. View

4.
Zhang Y, Yang Q, Li Y, Yu M, He G, Zhu Y . Inhibition of the Activating Transcription Factor 6 Branch of Endoplasmic Reticulum Stress Ameliorates Brain Injury after Deep Hypothermic Circulatory Arrest. J Clin Med. 2023; 12(3). PMC: 9917384. DOI: 10.3390/jcm12030814. View

5.
Diwakar L, Ravindranath V . Inhibition of cystathionine-gamma-lyase leads to loss of glutathione and aggravation of mitochondrial dysfunction mediated by excitatory amino acid in the CNS. Neurochem Int. 2006; 50(2):418-26. DOI: 10.1016/j.neuint.2006.09.014. View